Ariad files new blood cancer drug with the FDA

July 31, 2012
Research and Development, Sales and Marketing Ariad, CML, EMA, FDA, Glivec, blood cancer

Ariad has filed its investigational blood cancer drug ponatinib with the FDA and hopes for an accelerated review. The US …

Astrazeneca image

AstraZeneca launches virtual research laboratory

July 31, 2012
Medical Communications Assay Depot, AstraZeneca, R&D, virtual

AstraZeneca and partner Assay Depot have launched a virtual research laboratory aimed at helping its scientists create R&D collaborations. The …

tulstrup

Soren Tulstrup to lead Shire’s genetics franchise

July 31, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Shire has appointed Soren Tulstrup as its new senior vice president and franchise lead, MPS (mucopolysaccharides) for its human genetic …

Bayer raises guidance after strong sales

July 31, 2012
Sales and Marketing Bayer, Nexavar, Q2, Xarelto, Yasmin

The Bayer Group has raised its full-year guidance for 2012 following positive results in the second quarter. This is despite …

fda_building

Fitch to pharma: don’t expect 2012 to be a bumper year

July 31, 2012
Sales and Marketing 2012, FDA approvals, Fitch, IMS Health, NMEs, ratings

The Fitch ratings agency has published pessimistic projections for pharma, saying that it should not expect as many US drug …

Leading producer of auto injectors SHL hires over 600 new employees

July 31, 2012
Manufacturing and Production auto injector, autoinjector, pen injector, shl group

In response to increased customer orders and the signing of long-term contracts, SHL has hired more than 600 new employees …

Merck image

Merck sees growth in second quarter

July 30, 2012
Sales and Marketing Cozaar, Merck, Q2, Singulair

Merck has posted a healthy sales increase for the second quarter, as its established drugs grew strongly. Sales increased 1% …

Parkinson’s specialist spins out from Merck Serono’s Swiss R&D ops

July 30, 2012
Research and Development, Sales and Marketing Merck Serono, Parkinson's, Prexton, Swiss

A company specialising in novel treatments for Parkinson’s disease is the first to be spun out of Merck Serono’s soon-to-close …

Bayer image

Bayer guilty of multiple Code breaches

July 30, 2012
Medical Communications, Sales and Marketing ABPI Code, Bayer, Xarelto, breach, clause

Bayer Healthcare has admitted to 12 breaches of the ABPI Code after one of its staff developed and distributed drug …

david-meek

Novartis’ David Meek moves to Endocyte

July 30, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Endocyte, Novartis, appointment

David Meek has been appointed to the newly created position of chief commercial officer at the biotechnology firm Endocyte. Meek …

immatics image

immatics’ vaccine increases survival in kidney cancer

July 30, 2012
Research and Development, Sales and Marketing IMA901, Vaccine, Yervoy, immatics, phase III

immatics’ investigational cancer vaccine has increased survival rates in patients with renal cell carcinoma. In a late-stage trial, the German …

J&J image

J&J expects consent decree to extend through ‘most of 2013’

July 30, 2012
Manufacturing and Production FDA, J&J, JJ, McNeil, OTC, recall

Johnson & Johnson has said it expects the production capacity issues affecting two plants covered by a consent decree with …

Prevenar 13 image

Prevenar 13 rejected for UK vaccination programme

July 27, 2012
Sales and Marketing JCVI, Pfizer, Pneumovax, Sanofi Pasteur, prevenar 13

The UK’s joint committee on vaccination and immunisation is recommending against a switch to Pfizer’s pneumococcal vaccine Prevenar 13 from …

screen_shot_2012-07-27_at_11

IT problems at Swedish plant affect AstraZeneca

July 27, 2012
Manufacturing and Production AstraZeneca, Nexium, Symbicort, financials

Software problems at a manufacturing facility operated by AstraZeneca in Sweden are having a material impact on the business, pegging …

Roche image

Roche posts strong sales results

July 27, 2012
Sales and Marketing Pegasys, Perjeta, Roche, Zelboraf, dalcetrapib

Roche has published healthy revenue growth for the first half of 2012, but its profits have taken a hit. The …

d-heymann

Acting chair of Public Health England appointed

July 26, 2012
Sales and Marketing David Heymann, Public Health England

David Heymann has been appointed as the acting chair of Public Health England. Dr Heymann, currently chairman of the Health …

Astrazeneca image

AstraZeneca’s Fluenz chosen for wider flu immunisation

July 26, 2012
Sales and Marketing AZ, AstraZeneca, Cervarix, Gardasil, Lansley, MedImmune

The UK has chosen AstraZeneca’s Fluenz to extend the country’s flu vaccination programme. The health secretary Andrew Lansley said that …

Astrazeneca image

AstraZeneca sees big sales drop in Q2

July 26, 2012
Sales and Marketing AstraZeneca, Brennan, Brilinta, Q2, Seroquel

AstraZeneca has today reported a large drop in revenue for the second quarter. The firm has been hit by major …

Care4today image

Janssen launches drug reminder service ‘Care4Today’

July 26, 2012
Medical Communications Care4Today, Janssen, digital

Janssen has launched a new digital service designed to help patients remember to take their medication. Care4Today Mobile Adherence is …

The fight over ‘Obamacare’ goes on

July 26, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Medicaid, Obama, Obamacare, Romney, US, healthcare

The recent ruling by the US Supreme Court which upheld President Obama’s healthcare reforms could save the country around $84 …

The Gateway to Local Adoption Series

Latest content